These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 24439602

  • 1. Targeting Aurora kinase-A downregulates cell proliferation and angiogenesis in neuroblastoma.
    Romain C, Paul P, Kim KW, Lee S, Qiao J, Chung DH.
    J Pediatr Surg; 2014 Jan; 49(1):159-65. PubMed ID: 24439602
    [Abstract] [Full Text] [Related]

  • 2. PHA-680626 Is an Effective Inhibitor of the Interaction between Aurora-A and N-Myc.
    Boi D, Souvalidou F, Capelli D, Polverino F, Marini G, Montanari R, Pochetti G, Tramonti A, Contestabile R, Trisciuoglio D, Carpinelli P, Ascanelli C, Lindon C, De Leo A, Saviano M, Di Santo R, Costi R, Guarguaglini G, Paiardini A.
    Int J Mol Sci; 2021 Dec 04; 22(23):. PubMed ID: 34884931
    [Abstract] [Full Text] [Related]

  • 3. c-Myc Is a Major Determinant for Antitumor Activity of Aurora A Kinase Inhibitor MLN8237 in Thyroid Cancer.
    Li Y, Li X, Pu J, Yang Q, Guan H, Ji M, Shi B, Chen M, Hou P.
    Thyroid; 2018 Dec 04; 28(12):1642-1654. PubMed ID: 30226440
    [Abstract] [Full Text] [Related]

  • 4. Dual BRD4 and AURKA Inhibition Is Synergistic against MYCN-Amplified and Nonamplified Neuroblastoma.
    Felgenhauer J, Tomino L, Selich-Anderson J, Bopp E, Shah N.
    Neoplasia; 2018 Oct 04; 20(10):965-974. PubMed ID: 30153557
    [Abstract] [Full Text] [Related]

  • 5. Polymer Nanovesicle-Mediated Delivery of MLN8237 Preferentially Inhibits Aurora Kinase A To Target RalA and Anchorage-Independent Growth in Breast Cancer Cells.
    Inchanalkar S, Deshpande NU, Kasherwal V, Jayakannan M, Balasubramanian N.
    Mol Pharm; 2018 Aug 06; 15(8):3046-3059. PubMed ID: 29863884
    [Abstract] [Full Text] [Related]

  • 6. A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer.
    Dauch D, Rudalska R, Cossa G, Nault JC, Kang TW, Wuestefeld T, Hohmeyer A, Imbeaud S, Yevsa T, Hoenicke L, Pantsar T, Bozko P, Malek NP, Longerich T, Laufer S, Poso A, Zucman-Rossi J, Eilers M, Zender L.
    Nat Med; 2016 Jul 06; 22(7):744-53. PubMed ID: 27213815
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of Aurora A Kinase in Combination with Chemotherapy Induces Synthetic Lethality and Overcomes Chemoresistance in Myc-Overexpressing Lymphoma.
    Park SI, Lin CP, Ren N, Angus SP, Dittmer DP, Foote M, Parton T, Bhatt AP, Fedoriw YD, Roth DP, Cann ML, Johnson GL, Damania B.
    Target Oncol; 2019 Oct 06; 14(5):563-575. PubMed ID: 31429028
    [Abstract] [Full Text] [Related]

  • 8. Cisplatin-resistant cancer cells are sensitive to Aurora kinase A inhibition by alisertib.
    Wang L, Arras J, Katsha A, Hamdan S, Belkhiri A, Ecsedy J, El-Rifai W.
    Mol Oncol; 2017 Aug 06; 11(8):981-995. PubMed ID: 28417568
    [Abstract] [Full Text] [Related]

  • 9. Concurrent Inhibition of Neurosphere and Monolayer Cells of Pediatric Glioblastoma by Aurora A Inhibitor MLN8237 Predicted Survival Extension in PDOX Models.
    Kogiso M, Qi L, Braun FK, Injac SG, Zhang L, Du Y, Zhang H, Lin FY, Zhao S, Lindsay H, Su JM, Baxter PA, Adesina AM, Liao D, Qian MG, Berg S, Muscal JA, Li XN.
    Clin Cancer Res; 2018 May 01; 24(9):2159-2170. PubMed ID: 29463553
    [Abstract] [Full Text] [Related]

  • 10. Aurora kinase A promotes inflammation and tumorigenesis in mice and human gastric neoplasia.
    Katsha A, Soutto M, Sehdev V, Peng D, Washington MK, Piazuelo MB, Tantawy MN, Manning HC, Lu P, Shyr Y, Ecsedy J, Belkhiri A, El-Rifai W.
    Gastroenterology; 2013 Dec 01; 145(6):1312-22.e1-8. PubMed ID: 23993973
    [Abstract] [Full Text] [Related]

  • 11. Aurora kinases as targets in drug-resistant neuroblastoma cells.
    Michaelis M, Selt F, Rothweiler F, Löschmann N, Nüsse B, Dirks WG, Zehner R, Cinatl J.
    PLoS One; 2014 Dec 01; 9(9):e108758. PubMed ID: 25268132
    [Abstract] [Full Text] [Related]

  • 12. Aurora kinase A mediates epithelial ovarian cancer cell migration and adhesion.
    Do TV, Xiao F, Bickel LE, Klein-Szanto AJ, Pathak HB, Hua X, Howe C, O'Brien SW, Maglaty M, Ecsedy JA, Litwin S, Golemis EA, Schilder RJ, Godwin AK, Connolly DC.
    Oncogene; 2014 Jan 30; 33(5):539-49. PubMed ID: 23334327
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of AURKA Reduces Proliferation and Survival of Gastrointestinal Cancer Cells With Activated KRAS by Preventing Activation of RPS6KB1.
    Wang-Bishop L, Chen Z, Gomaa A, Lockhart AC, Salaria S, Wang J, Lewis KB, Ecsedy J, Washington K, Beauchamp RD, El-Rifai W.
    Gastroenterology; 2019 Feb 30; 156(3):662-675.e7. PubMed ID: 30342037
    [Abstract] [Full Text] [Related]

  • 14. Small molecule inhibitors of aurora-a induce proteasomal degradation of N-myc in childhood neuroblastoma.
    Brockmann M, Poon E, Berry T, Carstensen A, Deubzer HE, Rycak L, Jamin Y, Thway K, Robinson SP, Roels F, Witt O, Fischer M, Chesler L, Eilers M.
    Cancer Cell; 2013 Jul 08; 24(1):75-89. PubMed ID: 23792191
    [Abstract] [Full Text] [Related]

  • 15. The AURKA/TPX2 axis drives colon tumorigenesis cooperatively with MYC.
    Takahashi Y, Sheridan P, Niida A, Sawada G, Uchi R, Mizuno H, Kurashige J, Sugimachi K, Sasaki S, Shimada Y, Hase K, Kusunoki M, Kudo S, Watanabe M, Yamada K, Sugihara K, Yamamoto H, Suzuki A, Doki Y, Miyano S, Mori M, Mimori K.
    Ann Oncol; 2015 May 08; 26(5):935-942. PubMed ID: 25632068
    [Abstract] [Full Text] [Related]

  • 16. Aurora kinase targeting in lung cancer reduces KRAS-induced transformation.
    Dos Santos EO, Carneiro-Lobo TC, Aoki MN, Levantini E, Bassères DS.
    Mol Cancer; 2016 Feb 03; 15():12. PubMed ID: 26842935
    [Abstract] [Full Text] [Related]

  • 17. San Huang Decoction Targets Aurora Kinase A to Inhibit Tumor Angiogenesis in Breast Cancer.
    Xu Y, Wang C, Chen X, Li Y, Bian W, Yao C.
    Integr Cancer Ther; 2020 Feb 03; 19():1534735420983463. PubMed ID: 33349071
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of mitotic Aurora kinase A by alisertib induces apoptosis and autophagy of human gastric cancer AGS and NCI-N78 cells.
    Yuan CX, Zhou ZW, Yang YX, He ZX, Zhang X, Wang D, Yang T, Wang NJ, Zhao RJ, Zhou SF.
    Drug Des Devel Ther; 2015 Feb 03; 9():487-508. PubMed ID: 25609923
    [Abstract] [Full Text] [Related]

  • 19. Targeting aurora kinase A inhibits hypoxia-mediated neuroblastoma cell tumorigenesis.
    Romain CV, Paul P, Lee S, Qiao J, Chung DH.
    Anticancer Res; 2014 May 03; 34(5):2269-74. PubMed ID: 24778030
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of Aurora A enhances radiosensitivity in selected lung cancer cell lines.
    Liu N, Wang YA, Sun Y, Ecsedy J, Sun J, Li X, Wang P.
    Respir Res; 2019 Oct 23; 20(1):230. PubMed ID: 31647033
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.